Written by Klarity Editorial Team
Published: Jul 18, 2026

Last updated: July 18, 2026
Key facts: Anthem Blue Cross Blue Shield of New Hampshire uses Prime Therapeutics as its pharmacy benefit manager (PBM). Most depression medications are non-scheduled and are not subject to New Hampshire EPCS rules (RSA 318-B:21-a). EPCS is entirely inapplicable for standard antidepressants. The exception is Spravato (esketamine), a Schedule III controlled substance, which does require electronic prescribing in NH under the broad RSA 318-B:21-a mandate. NH mental health parity is governed by RSA 417-E:1. Coverage verification is always recommended before scheduling care.
If you have an Anthem Blue Cross Blue Shield plan in New Hampshire and are seeking depression treatment, understanding your formulary, prior authorization process, and state-specific EPCS requirements may help you navigate coverage more effectively. This guide explains how Anthem NH may cover depression medications, what the Prime Therapeutics formulary typically looks like, and which regulatory rules apply to your plan.
See If You May Qualify for Depression Treatment →
Anthem Blue Cross Blue Shield offers commercial health plans in New Hampshire including individual and family plans through the NH Health Insurance Marketplace, employer-sponsored group plans (both fully insured and self-funded), and Medicare Supplement plans. Anthem NH partners with Prime Therapeutics as its pharmacy benefit manager for prescription drug coverage across commercial lines.
Prime Therapeutics processes prior authorization requests, manages the drug formulary, and handles specialty drug programs for most Anthem NH commercial members. Some large self-funded employer groups may use a different PBM. Confirm your specific plan documents or call the member services number on your insurance card.
The Prime Therapeutics formulary for Anthem NH commercial plans generally organizes depression medications across four tiers. Generic first-line antidepressants are typically in Tier 1. 2 with low or no prior authorization requirements. Brand-name antidepressants and specialty drugs are in Tier 3. 4 and often require step therapy or prior authorization. Specific tier placement and PA requirements may vary by plan year and employer group.
| Medication | Drug Class | Typical Tier | PA Required? | NH EPCS (RSA 318-B:21-a) |
|---|---|---|---|---|
| Sertraline (generic Zoloft) | SSRI | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Escitalopram (generic Lexapro) | SSRI | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Fluoxetine (generic Prozac) | SSRI | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Paroxetine (generic Paxil) | SSRI | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Citalopram (generic Celexa) | SSRI | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Lexapro (brand) | SSRI (brand) | Tier 3. 4 | Step therapy | Not scheduled. EPCS inapplicable |
| Venlafaxine ER (generic Effexor XR) | SNRI | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Duloxetine (generic Cymbalta) | SNRI | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Effexor XR (brand) | SNRI (brand) | Tier 3. 4 | Step therapy | Not scheduled. EPCS inapplicable |
| Bupropion / Bupropion XL | NDRI | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Mirtazapine | NaSSA | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Amitriptyline / Nortriptyline | TCA | Tier 1. 2 | Rarely | Not scheduled. EPCS inapplicable |
| Trintellix (vortioxetine) | SMS | Tier 3. 4 | PA likely | Not scheduled. EPCS inapplicable |
| Auvelity (dextromethorphan/bupropion) | NMDA antagonist | Tier 3. 4 | PA likely | Not scheduled. EPCS inapplicable |
| Spravato (esketamine nasal spray) | NMDA antagonist. Specialty | Specialty tier | PA + REMS required | Schedule III. EPCS REQUIRED in NH |
Tier placement and PA requirements reflect general Prime Therapeutics commercial formulary patterns for 2026. Verify your specific plan’s current formulary at anthem.com or by calling 1-855-634-3577.
New Hampshire’s Electronic Prescribing for Controlled Substances law, RSA 318-B:21-a, requires electronic prescribing for controlled substances in Schedules II through V. This is one of the broadest EPCS mandates in the country. Broader than Hawaii (HRS § 329-38.5, which covers Schedule II only) and similar in scope to West Virginia (§ 60A-4-403a).
For depression medications, the EPCS analysis produces a clear split result:
In practice, the overwhelming majority of patients receiving Anthem NH depression coverage will receive non-scheduled antidepressants where EPCS is entirely inapplicable. Spravato is a treatment-resistant depression option dispensed in-clinic under medical supervision and subject to FDA REMS. Its Schedule III status and NH EPCS requirement are handled at the prescribing provider level.
Prime Therapeutics manages prior authorization for prescription depression medications under Anthem NH commercial plans. The general prior authorization process involves:
New Hampshire’s mental health parity law, RSA 417-E:1 et seq., requires fully insured commercial health plans to cover mental health and substance use disorder (MH/SUD) benefits. Including depression treatment. On terms no more restrictive than comparable medical or surgical benefits. This means prior authorization criteria, step therapy requirements, and quantitative treatment limits for depression medications must be comparable to those applied to equivalent physical health medications under the same Anthem NH plan.
Key RSA 417-E:1 protections for Anthem NH members:
New Hampshire also maintains telehealth parity under RSA 415-J:2, which may require Anthem NH to cover depression-related telehealth visits on terms comparable to in-person care.
Anthem NH commercial plans may provide coverage for medically necessary treatment of a range of depressive disorders, including:
Coverage for specific diagnoses and medications is always subject to your plan’s medical necessity criteria and formulary. Verify your benefits before initiating treatment.
Before scheduling an appointment, consider these steps to verify your depression treatment coverage:
Klarity Health connects patients with licensed providers across New Hampshire who can evaluate and treat depression. Klarity’s network includes more than 2,000 licensed providers across specialties including psychiatry, primary care, and mental health. Providers can discuss treatment options, review your current medications, and. Where clinically appropriate. Prescribe antidepressant medications through a secure telehealth appointment.
Klarity can help verify whether your Anthem NH plan may cover your appointment before you book.
Check If You May Qualify for Depression Treatment →
Anthem NH commercial plans typically cover generic antidepressants including sertraline and escitalopram at Tier 1. 2 through Prime Therapeutics, often with low or no prior authorization requirement. Your specific plan’s formulary and cost-sharing may vary. Verify at anthem.com or call 1-855-634-3577.
For most antidepressants. SSRIs, SNRIs, bupropion, mirtazapine, and TCAs. No. These medications are non-scheduled and NH EPCS rules under RSA 318-B:21-a do not apply. The only depression medication that triggers NH EPCS is Spravato (esketamine), which is Schedule III. Providers prescribing Spravato in NH must use an electronic prescribing system.
Step therapy means Prime Therapeutics may require documented use of a lower-tier (typically generic) medication before approving a brand-name antidepressant. For example, coverage of brand Lexapro may require a prior trial of generic escitalopram. Your provider can document this in the PA request. RSA 417-E:1 parity rules may limit how restrictive these step therapy requirements can be relative to comparable physical health drugs.
Spravato (esketamine nasal spray) is a specialty-tier medication used for treatment-resistant depression. Coverage under Anthem NH commercial plans typically requires prior authorization, clinical documentation of treatment-resistant depression (failure of multiple prior antidepressants), and compliance with FDA REMS. Spravato is administered in a certified healthcare setting under medical supervision. It is not dispensed for home use. Because Spravato is Schedule III, NH EPCS under RSA 318-B:21-a applies to the prescribing provider. Contact Anthem at 1-855-634-3577 for current coverage criteria.
RSA 417-E:1 requires Anthem NH fully insured commercial plans to cover depression treatment on terms no more restrictive than comparable medical or surgical benefits. If you believe your PA was denied in a way that would not apply to equivalent physical health care, you may file an internal appeal with Anthem and an external appeal with the NH Insurance Department at 1-800-852-3416.
Anthem NH commercial plans may cover telehealth mental health visits including depression consultations. New Hampshire’s telehealth parity law (RSA 415-J:2) may require coverage of telehealth depression services on terms comparable to in-person care. Confirm telehealth benefits and any applicable cost-sharing with Anthem at 1-855-634-3577 before your appointment.
Disclaimer: Coverage information on this page is for general educational purposes only. Formulary tiers, prior authorization requirements, and plan benefits vary by Anthem NH plan type, plan year, and employer group. Coverage for specific medications and services is not guaranteed. Always verify your current benefits directly with Anthem Blue Cross Blue Shield NH and Prime Therapeutics before initiating treatment. Klarity Health does not guarantee insurance coverage and is not affiliated with Anthem or Prime Therapeutics.
Find the right provider for your needs — select your state to find expert care near you.